Sharif-Kazemi Mohammad B, Emkanjoo Zahra, Tavoosi Amir, Kafi Mohammad, Kheirkhah Jalal, Alizadeh Abolfath, Sadr-Ameli Mohammad A
Department of Pacemaker and Electrophysiology, Rajaie Cardiovascular Research and Medical Center, Tehran, Iran.
Pacing Clin Electrophysiol. 2011 Feb;34(2):e18-21. doi: 10.1111/j.1540-8159.2010.02740.x.
Clinical and molecular characterization of the Brugada syndrome has progressed rapidly since its initial description. The role of hormonal changes during pregnancy and postpartum period on the pathogenesis of Brugada syndrome has not been studied. Herein, we describe a case of revelation of Brugada syndrome during pregnancy in a young woman who presented with electrical storm as the first manifestation. Low-dose isoproterenol infusion followed by oral quinidine inhibited the recurrence of ventricular tachyarrhythmia and normalized the electrocardiographic pattern. We emphasize the importance of hormonal changes during pregnancy as a precipitating factor for arrhythmic events in Brugada syndrome.
自最初描述以来,Brugada综合征的临床和分子特征进展迅速。孕期及产后激素变化在Brugada综合征发病机制中的作用尚未得到研究。在此,我们描述了一名年轻女性在孕期出现Brugada综合征的病例,其首发表现为电风暴。低剂量静脉输注异丙肾上腺素后口服奎尼丁抑制了室性快速心律失常的复发,并使心电图模式恢复正常。我们强调孕期激素变化作为Brugada综合征心律失常事件促发因素的重要性。